admp Search Results


93
Proteintech adamts4
Adamts4, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/admp/ADAMTS4+Antibody/pm38105181-239-18-26
Average 93 stars, based on 1 article reviews
adamts4 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

97
ABclonal Biotechnology adamts5
Figure 2. EOGT knockdown alleviated IL-1β-induced chondrocyte inflammatory injury. EOGT knockdown was induced in IL-1β- treated chondrocytes. (A) IL-6 and IL-8 secretion levels in chondrocytes were assessed by ELISA. (B-C) IF was adopted to detect MMP13 and <t>ADAMTS5</t> fluorescence intensity in chondrocytes. Data were expressed as mean ± SD. All our data were obtained from 3 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001. EOGT = epidermal growth factor–like domain–specific O-GlcNAc transferase; IL-1β = interleukin-1 beta; ELISA = enzyme-linked immunosorbent assay.
Adamts5, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/admp/ADAMTS5+Rabbit+pAb/pm38366389-58-15-16
Average 97 stars, based on 1 article reviews
adamts5 - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

94
ABclonal Biotechnology anti adamts4
Figure 2. EOGT knockdown alleviated IL-1β-induced chondrocyte inflammatory injury. EOGT knockdown was induced in IL-1β- treated chondrocytes. (A) IL-6 and IL-8 secretion levels in chondrocytes were assessed by ELISA. (B-C) IF was adopted to detect MMP13 and <t>ADAMTS5</t> fluorescence intensity in chondrocytes. Data were expressed as mean ± SD. All our data were obtained from 3 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001. EOGT = epidermal growth factor–like domain–specific O-GlcNAc transferase; IL-1β = interleukin-1 beta; ELISA = enzyme-linked immunosorbent assay.
Anti Adamts4, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/admp/ADAMTS4+Rabbit+pAb/pmc09820994-200-22-25
Average 94 stars, based on 1 article reviews
anti adamts4 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

92
Proteintech adamts5
Influence of the meniscus on articular cartilage during the development of PTOA (A) . The immunofluorescence staining results of MMP13 in 1 week, 2 and 3 weeks after ACLT surgery (Scale bar: the left panel was 100 um, the middle and the right panel was 25 um). (B) The statistics of MMP13-positive cells in tibia (C) . The statistics of MMP13-positive cells in meniscus (D) . The expression of <t>Adamts5</t> and MMP13 in Western Blot (E) . The gray value statistics of Adamts5 (F) The gray value statistics of MMP13.
Adamts5, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/admp/ADAMTS5+Fusion+Protein/pmc09479128-61-61-79
Average 92 stars, based on 1 article reviews
adamts5 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

93
Boster Bio adamts5 102
Influence of the meniscus on articular cartilage during the development of PTOA (A) . The immunofluorescence staining results of MMP13 in 1 week, 2 and 3 weeks after ACLT surgery (Scale bar: the left panel was 100 um, the middle and the right panel was 25 um). (B) The statistics of MMP13-positive cells in tibia (C) . The statistics of MMP13-positive cells in meniscus (D) . The expression of <t>Adamts5</t> and MMP13 in Western Blot (E) . The gray value statistics of Adamts5 (F) The gray value statistics of MMP13.
Adamts5 102, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/admp/Anti-ATS5+ADAMTS5+Antibody/10__2139_slash_ssrn__4246389-43-6-29
Average 93 stars, based on 1 article reviews
adamts5 102 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
OriGene adamts 5
Influence of the meniscus on articular cartilage during the development of PTOA (A) . The immunofluorescence staining results of MMP13 in 1 week, 2 and 3 weeks after ACLT surgery (Scale bar: the left panel was 100 um, the middle and the right panel was 25 um). (B) The statistics of MMP13-positive cells in tibia (C) . The statistics of MMP13-positive cells in meniscus (D) . The expression of <t>Adamts5</t> and MMP13 in Western Blot (E) . The gray value statistics of Adamts5 (F) The gray value statistics of MMP13.
Adamts 5, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/admp/ADAMTS5+(NM_007038)+Human+Tagged+ORF+Clone/pmc05355132-163-17-18
Average 90 stars, based on 1 article reviews
adamts 5 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
MedChemExpress xen45
Influence of the meniscus on articular cartilage during the development of PTOA (A) . The immunofluorescence staining results of MMP13 in 1 week, 2 and 3 weeks after ACLT surgery (Scale bar: the left panel was 100 um, the middle and the right panel was 25 um). (B) The statistics of MMP13-positive cells in tibia (C) . The statistics of MMP13-positive cells in meniscus (D) . The expression of <t>Adamts5</t> and MMP13 in Western Blot (E) . The gray value statistics of Adamts5 (F) The gray value statistics of MMP13.
Xen45, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/admp/ADAMTS5+Antibody/pmc11204868-125-15-19
Average 94 stars, based on 1 article reviews
xen45 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
OriGene human adamts4 cdna
Fig. 1. A schematic diagram of the study design. An acute study ending 4 weeks after SCI and another ending 13 weeks after SCI were conducted. To investigate transgene expression and toxicity resulting from the vector, animals were randomly assigned to three treatment groups and tissue was collected 4 weeks following 175 KDyne contusion injuries. To investigate the therapeutic benefit of <t>AAV-ADAMTS4</t> alone or in combination with hindlimb rehabilitation animals were randomly assigned to experimental groups and on day 0 received a 175 KDyne contusion injury at T10. Those in treatment groups received four injections of AAV-ADAMST4 at each corner of the injury site. Those assigned to the rehabilitation groups were subjected to hindlimb rehabilitation one week after the injury. At week 10, animals received injections of BDA into the hindlimb motor cortex for tracing of hindlimb CST axons. Three weeks later, the animals were euthanised and their spinal cords and brains were collected for histological analyses. This figure was produced using Servier Medical Art, available from www.servier.com/Powerpoint-image-bank. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.
Human Adamts4 Cdna, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/admp/ADAMTS4+(NM_005099)+Human+Tagged+ORF+Clone/pm32044329-54-3-6
Average 90 stars, based on 1 article reviews
human adamts4 cdna - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Molecular Dynamics Inc atom centered density matrix propagation molecular dynamics approach
Fig. 1. A schematic diagram of the study design. An acute study ending 4 weeks after SCI and another ending 13 weeks after SCI were conducted. To investigate transgene expression and toxicity resulting from the vector, animals were randomly assigned to three treatment groups and tissue was collected 4 weeks following 175 KDyne contusion injuries. To investigate the therapeutic benefit of <t>AAV-ADAMTS4</t> alone or in combination with hindlimb rehabilitation animals were randomly assigned to experimental groups and on day 0 received a 175 KDyne contusion injury at T10. Those in treatment groups received four injections of AAV-ADAMST4 at each corner of the injury site. Those assigned to the rehabilitation groups were subjected to hindlimb rehabilitation one week after the injury. At week 10, animals received injections of BDA into the hindlimb motor cortex for tracing of hindlimb CST axons. Three weeks later, the animals were euthanised and their spinal cords and brains were collected for histological analyses. This figure was produced using Servier Medical Art, available from www.servier.com/Powerpoint-image-bank. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.
Atom Centered Density Matrix Propagation Molecular Dynamics Approach, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/admp/atom+centered+density+matrix+propagation++admp+/pmc09229288-194-6-11
Average 90 stars, based on 1 article reviews
atom centered density matrix propagation molecular dynamics approach - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Molecular Dynamics Inc admp molecular dynamics
Fig. 1. A schematic diagram of the study design. An acute study ending 4 weeks after SCI and another ending 13 weeks after SCI were conducted. To investigate transgene expression and toxicity resulting from the vector, animals were randomly assigned to three treatment groups and tissue was collected 4 weeks following 175 KDyne contusion injuries. To investigate the therapeutic benefit of <t>AAV-ADAMTS4</t> alone or in combination with hindlimb rehabilitation animals were randomly assigned to experimental groups and on day 0 received a 175 KDyne contusion injury at T10. Those in treatment groups received four injections of AAV-ADAMST4 at each corner of the injury site. Those assigned to the rehabilitation groups were subjected to hindlimb rehabilitation one week after the injury. At week 10, animals received injections of BDA into the hindlimb motor cortex for tracing of hindlimb CST axons. Three weeks later, the animals were euthanised and their spinal cords and brains were collected for histological analyses. This figure was produced using Servier Medical Art, available from www.servier.com/Powerpoint-image-bank. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.
Admp Molecular Dynamics, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/admp/admp+molecular+dynamics/pmc06868892-159-0-1
Average 90 stars, based on 1 article reviews
admp molecular dynamics - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
FUJIFILM 4-amino-2,6-dimethylpyrimidine admp
Fig. 1. A schematic diagram of the study design. An acute study ending 4 weeks after SCI and another ending 13 weeks after SCI were conducted. To investigate transgene expression and toxicity resulting from the vector, animals were randomly assigned to three treatment groups and tissue was collected 4 weeks following 175 KDyne contusion injuries. To investigate the therapeutic benefit of <t>AAV-ADAMTS4</t> alone or in combination with hindlimb rehabilitation animals were randomly assigned to experimental groups and on day 0 received a 175 KDyne contusion injury at T10. Those in treatment groups received four injections of AAV-ADAMST4 at each corner of the injury site. Those assigned to the rehabilitation groups were subjected to hindlimb rehabilitation one week after the injury. At week 10, animals received injections of BDA into the hindlimb motor cortex for tracing of hindlimb CST axons. Three weeks later, the animals were euthanised and their spinal cords and brains were collected for histological analyses. This figure was produced using Servier Medical Art, available from www.servier.com/Powerpoint-image-bank. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.
4 Amino 2,6 Dimethylpyrimidine Admp, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/admp/4+amino+2+6+dimethylpyrimidine+admp/pm39986161-67-0-9
Average 90 stars, based on 1 article reviews
4-amino-2,6-dimethylpyrimidine admp - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Figure 2. EOGT knockdown alleviated IL-1β-induced chondrocyte inflammatory injury. EOGT knockdown was induced in IL-1β- treated chondrocytes. (A) IL-6 and IL-8 secretion levels in chondrocytes were assessed by ELISA. (B-C) IF was adopted to detect MMP13 and ADAMTS5 fluorescence intensity in chondrocytes. Data were expressed as mean ± SD. All our data were obtained from 3 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001. EOGT = epidermal growth factor–like domain–specific O-GlcNAc transferase; IL-1β = interleukin-1 beta; ELISA = enzyme-linked immunosorbent assay.

Journal: Cartilage

Article Title: HSF1 Increases EOGT-Mediated Glycosylation of Notch1 to Promote IL-1β-Induced Inflammatory Injury of Chondrocytes.

doi: 10.1177/19476035241229211

Figure Lengend Snippet: Figure 2. EOGT knockdown alleviated IL-1β-induced chondrocyte inflammatory injury. EOGT knockdown was induced in IL-1β- treated chondrocytes. (A) IL-6 and IL-8 secretion levels in chondrocytes were assessed by ELISA. (B-C) IF was adopted to detect MMP13 and ADAMTS5 fluorescence intensity in chondrocytes. Data were expressed as mean ± SD. All our data were obtained from 3 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001. EOGT = epidermal growth factor–like domain–specific O-GlcNAc transferase; IL-1β = interleukin-1 beta; ELISA = enzyme-linked immunosorbent assay.

Article Snippet: Cells were subsequently incubated overnight with antibodies against MMP13 (Proteintech, Wuhan, China; 1:500, 18165-1-AP) and AdAMTS5 (ABclonal, Wuhan, China; 1:200, A2836) for 2 h. Then, cells were incubated with the secondary antibody (Abcam; 1:3000, ab7090) for 1 h, and the nucleus was stained with DAPI (Sangon).

Techniques: Knockdown, Enzyme-linked Immunosorbent Assay, Fluorescence

Figure 3. HSF1 was highly expressed in IL-1β-treated chondrocytes and was involved in Notch1-mediated inflammatory injury. (A-B) HSF1 expression level in human chondrocytes after IL-1β stimulation was measured by RT-qPCR and western blot. (C-D) RT-qPCR and western blot were adopted to examine HSF1 expression level in human chondrocytes following si-NC or si-HSF1 transfection. HSF1 knockdown was induced in IL-1β-treated chondrocytes. (E-F) HSF1 expression in chondrocytes was measured by RT-qPCR and western blot. (G) Notch1 and NICD1 protein levels in cells were examined using western blot. (H) ELISA was adopted to detect IL-6 and IL-8 secretion levels in chondrocytes. (I-J) IF was adopted to detect MMP13 and ADAMTS5 fluorescence intensity in cells. Data were expressed as mean ± SD. All our data were obtained from 3 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001. HSF1 = heat-shock transcription factor 1; EOGT = epidermal growth factor–like domain–specific O-GlcNAc transferase; IL-1β = interleukin-1 beta; RT-qPCR = reverse transcription-quantitative polymerase chain reaction; ELISA = enzyme-linked immunosorbent assay; IF = immunofluorescence.

Journal: Cartilage

Article Title: HSF1 Increases EOGT-Mediated Glycosylation of Notch1 to Promote IL-1β-Induced Inflammatory Injury of Chondrocytes.

doi: 10.1177/19476035241229211

Figure Lengend Snippet: Figure 3. HSF1 was highly expressed in IL-1β-treated chondrocytes and was involved in Notch1-mediated inflammatory injury. (A-B) HSF1 expression level in human chondrocytes after IL-1β stimulation was measured by RT-qPCR and western blot. (C-D) RT-qPCR and western blot were adopted to examine HSF1 expression level in human chondrocytes following si-NC or si-HSF1 transfection. HSF1 knockdown was induced in IL-1β-treated chondrocytes. (E-F) HSF1 expression in chondrocytes was measured by RT-qPCR and western blot. (G) Notch1 and NICD1 protein levels in cells were examined using western blot. (H) ELISA was adopted to detect IL-6 and IL-8 secretion levels in chondrocytes. (I-J) IF was adopted to detect MMP13 and ADAMTS5 fluorescence intensity in cells. Data were expressed as mean ± SD. All our data were obtained from 3 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001. HSF1 = heat-shock transcription factor 1; EOGT = epidermal growth factor–like domain–specific O-GlcNAc transferase; IL-1β = interleukin-1 beta; RT-qPCR = reverse transcription-quantitative polymerase chain reaction; ELISA = enzyme-linked immunosorbent assay; IF = immunofluorescence.

Article Snippet: Cells were subsequently incubated overnight with antibodies against MMP13 (Proteintech, Wuhan, China; 1:500, 18165-1-AP) and AdAMTS5 (ABclonal, Wuhan, China; 1:200, A2836) for 2 h. Then, cells were incubated with the secondary antibody (Abcam; 1:3000, ab7090) for 1 h, and the nucleus was stained with DAPI (Sangon).

Techniques: Expressing, Quantitative RT-PCR, Western Blot, Transfection, Knockdown, Enzyme-linked Immunosorbent Assay, Fluorescence, Reverse Transcription, Real-time Polymerase Chain Reaction, Immunofluorescence

Influence of the meniscus on articular cartilage during the development of PTOA (A) . The immunofluorescence staining results of MMP13 in 1 week, 2 and 3 weeks after ACLT surgery (Scale bar: the left panel was 100 um, the middle and the right panel was 25 um). (B) The statistics of MMP13-positive cells in tibia (C) . The statistics of MMP13-positive cells in meniscus (D) . The expression of Adamts5 and MMP13 in Western Blot (E) . The gray value statistics of Adamts5 (F) The gray value statistics of MMP13.

Journal: Frontiers in Cell and Developmental Biology

Article Title: Enhancing autophagy and energy metabolism in the meniscus can delay the occurrence of PTOA in ACLT rat

doi: 10.3389/fcell.2022.971736

Figure Lengend Snippet: Influence of the meniscus on articular cartilage during the development of PTOA (A) . The immunofluorescence staining results of MMP13 in 1 week, 2 and 3 weeks after ACLT surgery (Scale bar: the left panel was 100 um, the middle and the right panel was 25 um). (B) The statistics of MMP13-positive cells in tibia (C) . The statistics of MMP13-positive cells in meniscus (D) . The expression of Adamts5 and MMP13 in Western Blot (E) . The gray value statistics of Adamts5 (F) The gray value statistics of MMP13.

Article Snippet: HE staining solution, Toluidine blue staining powder and safranin O/fast green staining powder was buy from Sigma (United States), SDS-PAGE gel rapid preparation kit was attained from Beyotime Biotechnology (Shanghai)Co., Ltd. rapamycin was acquired from Shanghai yuanye Bio-Technology Co., Ltd., IL-1β was purchased from R&D Systems (Bio-Techne), 3-methyladenine (3-MA, autophagy inhibitor) was produced from TargetMol (United States), primary antibodies MMP13 (18165-1-AP), Adamts5 (Ag26730), P-AKT (Phospho-AKT1 (Ser473)), Beclin 1 (11306-1-AP), LC-3B (18725-1-AP), ULK1 (20986-1-AP), ATG12 (11264-1-AP), COL1 (66761-1-lg) achieved from Proteintech Group, COL2 (GB11021) were procured from Servicebio (China), P-S6K (9208S)/S6K (9202S) were come from Cell Signaling Technology (CST), P62 (ab109012) was purchased from Abcam (Shanghai).

Techniques: Immunofluorescence, Staining, Expressing, Western Blot

Fig. 1. A schematic diagram of the study design. An acute study ending 4 weeks after SCI and another ending 13 weeks after SCI were conducted. To investigate transgene expression and toxicity resulting from the vector, animals were randomly assigned to three treatment groups and tissue was collected 4 weeks following 175 KDyne contusion injuries. To investigate the therapeutic benefit of AAV-ADAMTS4 alone or in combination with hindlimb rehabilitation animals were randomly assigned to experimental groups and on day 0 received a 175 KDyne contusion injury at T10. Those in treatment groups received four injections of AAV-ADAMST4 at each corner of the injury site. Those assigned to the rehabilitation groups were subjected to hindlimb rehabilitation one week after the injury. At week 10, animals received injections of BDA into the hindlimb motor cortex for tracing of hindlimb CST axons. Three weeks later, the animals were euthanised and their spinal cords and brains were collected for histological analyses. This figure was produced using Servier Medical Art, available from www.servier.com/Powerpoint-image-bank. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.

Journal: Experimental neurology

Article Title: Astrocyte-selective AAV-ADAMTS4 gene therapy combined with hindlimb rehabilitation promotes functional recovery after spinal cord injury.

doi: 10.1016/j.expneurol.2020.113232

Figure Lengend Snippet: Fig. 1. A schematic diagram of the study design. An acute study ending 4 weeks after SCI and another ending 13 weeks after SCI were conducted. To investigate transgene expression and toxicity resulting from the vector, animals were randomly assigned to three treatment groups and tissue was collected 4 weeks following 175 KDyne contusion injuries. To investigate the therapeutic benefit of AAV-ADAMTS4 alone or in combination with hindlimb rehabilitation animals were randomly assigned to experimental groups and on day 0 received a 175 KDyne contusion injury at T10. Those in treatment groups received four injections of AAV-ADAMST4 at each corner of the injury site. Those assigned to the rehabilitation groups were subjected to hindlimb rehabilitation one week after the injury. At week 10, animals received injections of BDA into the hindlimb motor cortex for tracing of hindlimb CST axons. Three weeks later, the animals were euthanised and their spinal cords and brains were collected for histological analyses. This figure was produced using Servier Medical Art, available from www.servier.com/Powerpoint-image-bank. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.

Article Snippet: A plasmid containing human ADAMTS4 cDNA (Origene: RC09226; NM_005099) was used as a template and amplified using a ThermoFisher Accuprime PCR kit as per the manufacturer's instructions and the forward primer 5′ TAT TAT ACT AGT GCT GCA GTA CCA GTG CCA TG 3′ and the reverse primer 5′ CTA GTA AAG CTT CGG GAT AGT GAG GTT ATT TC 3′ (Fig. S1a) The ADAMTS4 PCR product was then purified and cloned into an AAV expression plasmid; the ADAMTS4 transgene was followed by a woodchuck hepatitis virus post-transcriptional regulatory element (WPRE) and bovine growth hormone polyadenylation signal (BGHpA), flanked by AAV2 inverted terminal repeats.

Techniques: Expressing, Plasmid Preparation, Produced

Fig. 3. AAV-ADAMTS4 transduces primary spinal cord astrocytes and degrades CSPG components. Primary spinal cord astrocytes were transduced with the AAV-ADAMTS4 vector (either 4 × 109 or 8 × 109 vg) and stimulated with 10 ng/mL TGFβ1 two days later. The cells were fixed three days after stimulation and fluorescent immunocytochemistry was then used to detect the ADAMTS4 transgene (ADAMTS4), chondroitin sulphate (CS56) and glycosaminoglycan (WFA). a) 10× magnification images were captured using a Nikon TE-2000-U microscope. Images were thresholded and arbitrary fluorescence units were measured for b) ADAMTS4, c) CS56 and d) WFA. Data represents mean ± SEM (n = 4 independent cultures). A one-way ANOVA followed by a Tukey's multiple comparisons test was used to test statistically significant differences *P < .05, **P < .001, ***P < .0001.

Journal: Experimental neurology

Article Title: Astrocyte-selective AAV-ADAMTS4 gene therapy combined with hindlimb rehabilitation promotes functional recovery after spinal cord injury.

doi: 10.1016/j.expneurol.2020.113232

Figure Lengend Snippet: Fig. 3. AAV-ADAMTS4 transduces primary spinal cord astrocytes and degrades CSPG components. Primary spinal cord astrocytes were transduced with the AAV-ADAMTS4 vector (either 4 × 109 or 8 × 109 vg) and stimulated with 10 ng/mL TGFβ1 two days later. The cells were fixed three days after stimulation and fluorescent immunocytochemistry was then used to detect the ADAMTS4 transgene (ADAMTS4), chondroitin sulphate (CS56) and glycosaminoglycan (WFA). a) 10× magnification images were captured using a Nikon TE-2000-U microscope. Images were thresholded and arbitrary fluorescence units were measured for b) ADAMTS4, c) CS56 and d) WFA. Data represents mean ± SEM (n = 4 independent cultures). A one-way ANOVA followed by a Tukey's multiple comparisons test was used to test statistically significant differences *P < .05, **P < .001, ***P < .0001.

Article Snippet: A plasmid containing human ADAMTS4 cDNA (Origene: RC09226; NM_005099) was used as a template and amplified using a ThermoFisher Accuprime PCR kit as per the manufacturer's instructions and the forward primer 5′ TAT TAT ACT AGT GCT GCA GTA CCA GTG CCA TG 3′ and the reverse primer 5′ CTA GTA AAG CTT CGG GAT AGT GAG GTT ATT TC 3′ (Fig. S1a) The ADAMTS4 PCR product was then purified and cloned into an AAV expression plasmid; the ADAMTS4 transgene was followed by a woodchuck hepatitis virus post-transcriptional regulatory element (WPRE) and bovine growth hormone polyadenylation signal (BGHpA), flanked by AAV2 inverted terminal repeats.

Techniques: Transduction, Plasmid Preparation, Immunocytochemistry, Microscopy

Fig. 5. ADAMTS4 gene therapy leads to significantly reduced lesion size. Luxol fast blue-eosin histology was used to investigate the integrity of spinal cord tissue following contusion (a), contusion and AAV-ADAMTS4 treatment (b), contusion with rehabilitation (c), and contusion with AAV-ADAMTS4 treatment and rehabilitation (D). Staining was used to determine the area of the lesion (e), white matter (f), total remaining tissue (g) and grey matter (h). Data represent mean ± SEM (contusion n = 10, contusion + AAV-ADAMTS4 n = 9; contu- sion + rehabilitation n = 12; contusion + AAV -ADAMTS4 + rehabilitation n = 9, sham + AAV-ADAMTS4 n = 4; scale = 1 mm). A Two-Way ANOVA and Bonferroni's multiple comparisons test were used to determine statistically significant differences. Results from the ANOVA tests comparing the mean group dif- ference between the contusion to contusion plus AAV-ADAMTS4 groups are displayed on the figures. *compares contusion to contusion plus AAV-ADAMTS4; #compares contusion plus rehabilitation to contusion plus rehabilitation plus AAV-ADAMTS4. For all figures: NS = Non significant, */#P < .05, **/##P < .001.

Journal: Experimental neurology

Article Title: Astrocyte-selective AAV-ADAMTS4 gene therapy combined with hindlimb rehabilitation promotes functional recovery after spinal cord injury.

doi: 10.1016/j.expneurol.2020.113232

Figure Lengend Snippet: Fig. 5. ADAMTS4 gene therapy leads to significantly reduced lesion size. Luxol fast blue-eosin histology was used to investigate the integrity of spinal cord tissue following contusion (a), contusion and AAV-ADAMTS4 treatment (b), contusion with rehabilitation (c), and contusion with AAV-ADAMTS4 treatment and rehabilitation (D). Staining was used to determine the area of the lesion (e), white matter (f), total remaining tissue (g) and grey matter (h). Data represent mean ± SEM (contusion n = 10, contusion + AAV-ADAMTS4 n = 9; contu- sion + rehabilitation n = 12; contusion + AAV -ADAMTS4 + rehabilitation n = 9, sham + AAV-ADAMTS4 n = 4; scale = 1 mm). A Two-Way ANOVA and Bonferroni's multiple comparisons test were used to determine statistically significant differences. Results from the ANOVA tests comparing the mean group dif- ference between the contusion to contusion plus AAV-ADAMTS4 groups are displayed on the figures. *compares contusion to contusion plus AAV-ADAMTS4; #compares contusion plus rehabilitation to contusion plus rehabilitation plus AAV-ADAMTS4. For all figures: NS = Non significant, */#P < .05, **/##P < .001.

Article Snippet: A plasmid containing human ADAMTS4 cDNA (Origene: RC09226; NM_005099) was used as a template and amplified using a ThermoFisher Accuprime PCR kit as per the manufacturer's instructions and the forward primer 5′ TAT TAT ACT AGT GCT GCA GTA CCA GTG CCA TG 3′ and the reverse primer 5′ CTA GTA AAG CTT CGG GAT AGT GAG GTT ATT TC 3′ (Fig. S1a) The ADAMTS4 PCR product was then purified and cloned into an AAV expression plasmid; the ADAMTS4 transgene was followed by a woodchuck hepatitis virus post-transcriptional regulatory element (WPRE) and bovine growth hormone polyadenylation signal (BGHpA), flanked by AAV2 inverted terminal repeats.

Techniques: Staining

Fig. 6. AAV-ADAMTS4 increases hindlimb CST collateral sprouting rostral to the lesion and serotonergic innervation caudal to the lesion. BDA was injected into the hindlimb motor cortex of rats 10 weeks after SCI. a) In untransduced animals, loaded axons were mainly confirmed to the CST 600–1200 μm rostral to the lesion edge, whereas treated animals displayed axon sprouting and growth widespread through grey matter (examples indicated by the red arrows; scale bar = 500 μm). ImageJ was used to quantify the total length of traced axons outside of the CST; transduced animals had a significantly greater amount of traced axons outside of the CST. b) Data represents the mean ± SEM. A two-tailed unpaired t-test was used to determine statistical differences between the two groups where *P < .05 (n = 7 for contusion + rehabilitation and contusion + AAV-ADAMTS4 + rehabilitation; n = 4 for contusion and contusion + AAV- ADAMTS4). c) Serotonergic fibers in the ventral horns of sections caudal to the injury (three sections: 600, 1200 and 1800 μm caudal to the injury were used; scale bar = 200 μm) were visualised. d) Images were consistently thresholded and the mean pixel intensity of serotonin immunoreactivity at the ventral horn was measured. Data represent the mean ± SEM (contusion n = 10; contusion + AAV-ADAMTS4 n = 7; contusion + rehabilitation n = 10; contusion + rehabilitation + AAV-ADAMTS4 n = 6). A one-way ANOVA followed by a Tukey's multiple comparisons test was used to test statistically significant differences where *P < .05, **P < .001. e) Protein kinase C gamma immunofluorescence confirmed that abolishment of the CST caudal to the lesion (indicated by *). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

Journal: Experimental neurology

Article Title: Astrocyte-selective AAV-ADAMTS4 gene therapy combined with hindlimb rehabilitation promotes functional recovery after spinal cord injury.

doi: 10.1016/j.expneurol.2020.113232

Figure Lengend Snippet: Fig. 6. AAV-ADAMTS4 increases hindlimb CST collateral sprouting rostral to the lesion and serotonergic innervation caudal to the lesion. BDA was injected into the hindlimb motor cortex of rats 10 weeks after SCI. a) In untransduced animals, loaded axons were mainly confirmed to the CST 600–1200 μm rostral to the lesion edge, whereas treated animals displayed axon sprouting and growth widespread through grey matter (examples indicated by the red arrows; scale bar = 500 μm). ImageJ was used to quantify the total length of traced axons outside of the CST; transduced animals had a significantly greater amount of traced axons outside of the CST. b) Data represents the mean ± SEM. A two-tailed unpaired t-test was used to determine statistical differences between the two groups where *P < .05 (n = 7 for contusion + rehabilitation and contusion + AAV-ADAMTS4 + rehabilitation; n = 4 for contusion and contusion + AAV- ADAMTS4). c) Serotonergic fibers in the ventral horns of sections caudal to the injury (three sections: 600, 1200 and 1800 μm caudal to the injury were used; scale bar = 200 μm) were visualised. d) Images were consistently thresholded and the mean pixel intensity of serotonin immunoreactivity at the ventral horn was measured. Data represent the mean ± SEM (contusion n = 10; contusion + AAV-ADAMTS4 n = 7; contusion + rehabilitation n = 10; contusion + rehabilitation + AAV-ADAMTS4 n = 6). A one-way ANOVA followed by a Tukey's multiple comparisons test was used to test statistically significant differences where *P < .05, **P < .001. e) Protein kinase C gamma immunofluorescence confirmed that abolishment of the CST caudal to the lesion (indicated by *). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

Article Snippet: A plasmid containing human ADAMTS4 cDNA (Origene: RC09226; NM_005099) was used as a template and amplified using a ThermoFisher Accuprime PCR kit as per the manufacturer's instructions and the forward primer 5′ TAT TAT ACT AGT GCT GCA GTA CCA GTG CCA TG 3′ and the reverse primer 5′ CTA GTA AAG CTT CGG GAT AGT GAG GTT ATT TC 3′ (Fig. S1a) The ADAMTS4 PCR product was then purified and cloned into an AAV expression plasmid; the ADAMTS4 transgene was followed by a woodchuck hepatitis virus post-transcriptional regulatory element (WPRE) and bovine growth hormone polyadenylation signal (BGHpA), flanked by AAV2 inverted terminal repeats.

Techniques: Injection, Two Tailed Test

Fig. 7. ADAMTS4 gene therapy with rehabilitation after thoracic spinal cord injury enhances improvements in behavioural assessments. The measured impaction force did not differ between treatment groups, confirming consistent injuries across all groups (a). The animals were weighed weekly as an indication of health status (b). BBB scores were measured for 10 weeks following the injury (c). Horizontal ladder testing began two weeks after injury where animals were recorded as they crossed a 1-meter horizontal ladder with irregular rungs. Data reported is the sum of the number of foot slips made for three runs. The data represents the mean ± SEM (contusion n = 14, contusion + AAV-ADAMTS4 n = 13; contusion + rehabilitation n = 12; contusion + AAV -ADAMTS4 + rehabilitation n = 9, sham + AAV- ADAMTS4 n = 4). A repeated measures two-way ANOVA was used to determine significant differences between the groups over time and a Bonferroni multiple comparisons test was used to determine differences at each time point where *P < .05, **P < .001, ***P < .0001. Red stars compares the contusion only group to the contusion + AAV-ADAMTS4 group, the yellow stars compares the contusion only group to the contusion + AAV -ADAMTS4 + rehabilitation group, and the purple stars compares the contusion + rehabilitation group to the contusion + AAV-ADAMTS4 + rehabilitation group. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

Journal: Experimental neurology

Article Title: Astrocyte-selective AAV-ADAMTS4 gene therapy combined with hindlimb rehabilitation promotes functional recovery after spinal cord injury.

doi: 10.1016/j.expneurol.2020.113232

Figure Lengend Snippet: Fig. 7. ADAMTS4 gene therapy with rehabilitation after thoracic spinal cord injury enhances improvements in behavioural assessments. The measured impaction force did not differ between treatment groups, confirming consistent injuries across all groups (a). The animals were weighed weekly as an indication of health status (b). BBB scores were measured for 10 weeks following the injury (c). Horizontal ladder testing began two weeks after injury where animals were recorded as they crossed a 1-meter horizontal ladder with irregular rungs. Data reported is the sum of the number of foot slips made for three runs. The data represents the mean ± SEM (contusion n = 14, contusion + AAV-ADAMTS4 n = 13; contusion + rehabilitation n = 12; contusion + AAV -ADAMTS4 + rehabilitation n = 9, sham + AAV- ADAMTS4 n = 4). A repeated measures two-way ANOVA was used to determine significant differences between the groups over time and a Bonferroni multiple comparisons test was used to determine differences at each time point where *P < .05, **P < .001, ***P < .0001. Red stars compares the contusion only group to the contusion + AAV-ADAMTS4 group, the yellow stars compares the contusion only group to the contusion + AAV -ADAMTS4 + rehabilitation group, and the purple stars compares the contusion + rehabilitation group to the contusion + AAV-ADAMTS4 + rehabilitation group. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

Article Snippet: A plasmid containing human ADAMTS4 cDNA (Origene: RC09226; NM_005099) was used as a template and amplified using a ThermoFisher Accuprime PCR kit as per the manufacturer's instructions and the forward primer 5′ TAT TAT ACT AGT GCT GCA GTA CCA GTG CCA TG 3′ and the reverse primer 5′ CTA GTA AAG CTT CGG GAT AGT GAG GTT ATT TC 3′ (Fig. S1a) The ADAMTS4 PCR product was then purified and cloned into an AAV expression plasmid; the ADAMTS4 transgene was followed by a woodchuck hepatitis virus post-transcriptional regulatory element (WPRE) and bovine growth hormone polyadenylation signal (BGHpA), flanked by AAV2 inverted terminal repeats.

Techniques: